Document is current

Any future updates will be listed below

1456 A phase I study of hSTC810 (Nelmastobart), an anti-BTN1A1 antibody, in patients with advanced solid tumors

Crossref DOI link: https://doi.org/10.1136/jitc-2024-SITC2024.1456

Published Online: 2024-11-05

Published Print: 2024-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark